2022 annual financial data
Janux Therapeutics 2022 Net margin
Direct answer
Net margin was -628.82%.
Operating income was -67,091,000 USD and net income was -54,154,000 USD.
Operating cash flow was Not available.
Get free Janux Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,612,000 USD
- Operating income
- -67,091,000 USD
- Net income
- -54,154,000 USD
- Operating cash flow
- Not available